메뉴 건너뛰기




Volumn 62, Issue 7, 2013, Pages 1223-1233

Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)

Author keywords

Adjuvant pegylated interferon alpha 2b; EORTC; Immunosuppressive cytokines; Interferon response genes; Melanoma; RT PCR

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; MESSENGER RNA; PEGINTERFERON ALPHA2B; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

EID: 84879551963     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-013-1428-4     Document Type: Article
Times cited : (7)

References (46)
  • 1
    • 0041409703 scopus 로고    scopus 로고
    • Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials
    • 12927565 10.1016/S0305-7372(03)00074-4 1:CAS:528:DC%2BD3sXmsVCns7s%3D
    • Wheatley K, Ives N, Hancock B, Gore M, Eggermont A, Suciu S (2003) Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials. Cancer Treat Rev 29(4):241-252
    • (2003) Cancer Treat Rev , vol.29 , Issue.4 , pp. 241-252
    • Wheatley, K.1    Ives, N.2    Hancock, B.3    Gore, M.4    Eggermont, A.5    Suciu, S.6
  • 2
    • 1842533233 scopus 로고    scopus 로고
    • A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma
    • 15014018 10.1158/1078-0432.CCR-1103-3 1:CAS:528:DC%2BD2cXhvFCltr4%3D
    • Kirkwood JM, Manola J, Ibrahim J, Sondak V, Ernstoff MS, Rao U (2004) A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma. Clin Cancer Res 10(5):1670-1677
    • (2004) Clin Cancer Res , vol.10 , Issue.5 , pp. 1670-1677
    • Kirkwood, J.M.1    Manola, J.2    Ibrahim, J.3    Sondak, V.4    Ernstoff, M.S.5    Rao, U.6
  • 4
    • 42449105247 scopus 로고    scopus 로고
    • Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease
    • 18320602 10.1002/cncr.23399 1:CAS:528:DC%2BD1cXmtFOlu74%3D
    • Anaya DA, Xing Y, Feng L, Huang X, Camacho LH, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Cormier JN (2008) Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease. Cancer 112(9):2030-2037
    • (2008) Cancer , vol.112 , Issue.9 , pp. 2030-2037
    • Anaya, D.A.1    Xing, Y.2    Feng, L.3    Huang, X.4    Camacho, L.H.5    Ross, M.I.6    Gershenwald, J.E.7    Lee, J.E.8    Mansfield, P.F.9    Cormier, J.N.10
  • 8
    • 35649015750 scopus 로고    scopus 로고
    • Interferon-α as adjuvant therapy for melanoma: An individual patient data meta-analysis of randomised trials
    • abstract 8526
    • Wheatley KIN, Eggermont A (2007) Interferon-α as adjuvant therapy for melanoma: an individual patient data meta-analysis of randomised trials. ASCO Annual Meeting Proceedings Part 1. J Clin Oncol 25(suppl 18S):abstract 8526
    • (2007) ASCO Annual Meeting Proceedings Part 1. J Clin Oncol , vol.25 , Issue.SUPPL. 18S
    • Wheatley, K.I.N.1    Eggermont, A.2
  • 9
    • 34347272251 scopus 로고    scopus 로고
    • Interferon-alpha and cancer: Mechanisms of action and new perspectives of clinical use
    • 17532550 10.1016/j.biochi.2007.04.006 1:CAS:528:DC%2BD2sXnsFKrurY%3D
    • Ferrantini M, Capone I, Belardelli F (2007) Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 89(6-7):884-893
    • (2007) Biochimie , vol.89 , Issue.6-7 , pp. 884-893
    • Ferrantini, M.1    Capone, I.2    Belardelli, F.3
  • 11
    • 0345829305 scopus 로고    scopus 로고
    • The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line
    • 14732359 10.1016/j.jss.2003.09.005 1:CAS:528:DC%2BD2cXltVGhsw%3D%3D
    • Badgwell B, Lesinski GB, Magro C, Abood G, Skaf A, Carson W 3rd (2004) The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line. J Surg Res 116(1):129-136
    • (2004) J Surg Res , vol.116 , Issue.1 , pp. 129-136
    • Badgwell, B.1    Lesinski, G.B.2    Magro, C.3    Abood, G.4    Skaf, A.5    Carson III, W.6
  • 13
    • 58149138892 scopus 로고    scopus 로고
    • Adjuvant therapy of melanoma with interferon: Lessons of the past decade
    • 18954464 10.1186/1479-5876-6-62
    • Ascierto PA, Kirkwood JM (2008) Adjuvant therapy of melanoma with interferon: lessons of the past decade. J Transl Med 6:62
    • (2008) J Transl Med , vol.6 , pp. 62
    • Ascierto, P.A.1    Kirkwood, J.M.2
  • 15
    • 33745989541 scopus 로고    scopus 로고
    • Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses
    • 16809739 10.1200/JCO.2005.05.2498 1:CAS:528:DC%2BD28XnslKhsL0%3D
    • Moschos SJ, Edington HD, Land SR, Rao UN, Jukic D, Shipe-Spotloe J, Kirkwood JM (2006) Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses. J Clin Oncol 24(19):3164-3171
    • (2006) J Clin Oncol , vol.24 , Issue.19 , pp. 3164-3171
    • Moschos, S.J.1    Edington, H.D.2    Land, S.R.3    Rao, U.N.4    Jukic, D.5    Shipe-Spotloe, J.6    Kirkwood, J.M.7
  • 16
    • 34249709048 scopus 로고    scopus 로고
    • Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma
    • 17488182 10.1371/journal.pmed.0040176
    • Critchley-Thorne RJ, Yan N, Nacu S, Weber J, Holmes SP, Lee PP (2007) Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. PLoS Med 4(5):e176
    • (2007) PLoS Med , vol.4 , Issue.5 , pp. 176
    • Critchley-Thorne, R.J.1    Yan, N.2    Nacu, S.3    Weber, J.4    Holmes, S.P.5    Lee, P.P.6
  • 17
    • 4444226259 scopus 로고    scopus 로고
    • Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy
    • 15339971 10.1093/jnci/djh252 1:CAS:528:DC%2BD2cXnsVyht7k%3D
    • Lesinski GB, Kondadasula SV, Crespin T, Shen L, Kendra K, Walker M, Carson WE 3rd (2004) Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. J Natl Cancer Inst 96(17):1331-1342
    • (2004) J Natl Cancer Inst , vol.96 , Issue.17 , pp. 1331-1342
    • Lesinski, G.B.1    Kondadasula, S.V.2    Crespin, T.3    Shen, L.4    Kendra, K.5    Walker, M.6    Carson III, W.E.7
  • 18
    • 52949111844 scopus 로고    scopus 로고
    • Inteferons pen the JAK-STAT pathway
    • 18765289 10.1016/j.semcdb.2008.08.010 1:CAS:528:DC%2BD1cXhtFOrur%2FJ
    • Schindler C, Plumlee C (2008) Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol 19(4):311-318
    • (2008) Semin Cell Dev Biol , vol.19 , Issue.4 , pp. 311-318
    • Schindler, C.1    Plumlee, C.2
  • 19
    • 17644402442 scopus 로고    scopus 로고
    • Type i interferons (alpha/beta) in immunity and autoimmunity
    • 15771573 10.1146/annurev.immunol.23.021704.115843 1:CAS:528: DC%2BD2MXktFOjur8%3D
    • Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307-336
    • (2005) Annu Rev Immunol , vol.23 , pp. 307-336
    • Theofilopoulos, A.N.1    Baccala, R.2    Beutler, B.3    Kono, D.H.4
  • 20
    • 41649103890 scopus 로고    scopus 로고
    • Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins
    • 18406369 10.1016/j.imbio.2007.10.008 1:CAS:528:DC%2BD1cXnsVGmsb8%3D
    • Dalpke A, Heeg K, Bartz H, Baetz A (2008) Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology 213(3-4):225-235
    • (2008) Immunobiology , vol.213 , Issue.3-4 , pp. 225-235
    • Dalpke, A.1    Heeg, K.2    Bartz, H.3    Baetz, A.4
  • 21
    • 34247107684 scopus 로고    scopus 로고
    • IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins
    • 17404264 1:CAS:528:DC%2BD2sXjslWjs7k%3D
    • Zimmerer JM, Lesinski GB, Kondadasula SV, Karpa VI, Lehman A, Raychaudhury A, Becknell B, Carson WE 3rd (2007) IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol 178(8):4832-4845
    • (2007) J Immunol , vol.178 , Issue.8 , pp. 4832-4845
    • Zimmerer, J.M.1    Lesinski, G.B.2    Kondadasula, S.V.3    Karpa, V.I.4    Lehman, A.5    Raychaudhury, A.6    Becknell, B.7    Carson III, W.E.8
  • 22
    • 0033104946 scopus 로고    scopus 로고
    • Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1
    • 10029571 1:CAS:528:DyaK1MXhsFertbs%3D
    • Ito S, Ansari P, Sakatsume M, Dickensheets H, Vazquez N, Donnelly RP, Larner AC, Finbloom DS (1999) Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93(5):1456-1463
    • (1999) Blood , vol.93 , Issue.5 , pp. 1456-1463
    • Ito, S.1    Ansari, P.2    Sakatsume, M.3    Dickensheets, H.4    Vazquez, N.5    Donnelly, R.P.6    Larner, A.C.7    Finbloom, D.S.8
  • 23
    • 13044290651 scopus 로고    scopus 로고
    • Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: Evidence for an IL-10-induced pathway that is independent of STAT protein activation
    • 10515892 1:CAS:528:DyaK1MXmslantbc%3D
    • Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, Scapini P, Marchi M, Suzuki R, Suzuki A, Yoshimura A (1999) Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 94(8):2880-2889
    • (1999) Blood , vol.94 , Issue.8 , pp. 2880-2889
    • Cassatella, M.A.1    Gasperini, S.2    Bovolenta, C.3    Calzetti, F.4    Vollebregt, M.5    Scapini, P.6    Marchi, M.7    Suzuki, R.8    Suzuki, A.9    Yoshimura, A.10
  • 24
    • 27144502396 scopus 로고    scopus 로고
    • TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4 + T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1
    • 16237056 1:CAS:528:DC%2BD2MXhtFahurrJ
    • Park IK, Shultz LD, Letterio JJ, Gorham JD (2005) TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4 + T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1. J Immunol 175(9):5666-5674
    • (2005) J Immunol , vol.175 , Issue.9 , pp. 5666-5674
    • Park, I.K.1    Shultz, L.D.2    Letterio, J.J.3    Gorham, J.D.4
  • 25
    • 0347296131 scopus 로고    scopus 로고
    • The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro
    • 12646633 1:CAS:528:DC%2BD3sXitFKltLw%3D
    • Fox SW, Haque SJ, Lovibond AC, Chambers TJ (2003) The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro. J Immunol 170(7):3679-3687
    • (2003) J Immunol , vol.170 , Issue.7 , pp. 3679-3687
    • Fox, S.W.1    Haque, S.J.2    Lovibond, A.C.3    Chambers, T.J.4
  • 27
    • 33947380550 scopus 로고    scopus 로고
    • Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy
    • 17267482 10.1128/JVI.02640-06 1:CAS:528:DC%2BD2sXjslWqs74%3D
    • Taylor MW, Tsukahara T, Brodsky L, Schaley J, Sanda C, Stephens MJ, McClintick JN, Edenberg HJ, Li L, Tavis JE, Howell C, Belle SH (2007) Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J Virol 81(7):3391-3401
    • (2007) J Virol , vol.81 , Issue.7 , pp. 3391-3401
    • Taylor, M.W.1    Tsukahara, T.2    Brodsky, L.3    Schaley, J.4    Sanda, C.5    Stephens, M.J.6    McClintick, J.N.7    Edenberg, H.J.8    Li, L.9    Tavis, J.E.10    Howell, C.11    Belle, S.H.12
  • 29
    • 12144288875 scopus 로고    scopus 로고
    • Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction
    • 15014010 10.1158/1078-0432.CCR-0610-3 1:CAS:528:DC%2BD2cXhvFClsbw%3D
    • Keilholz U, Goldin-Lang P, Bechrakis NE, Max N, Letsch A, Schmittel A, Scheibenbogen C, Heufelder K, Eggermont A, Thiel E (2004) Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction. Clin Cancer Res 10(5):1605-1612
    • (2004) Clin Cancer Res , vol.10 , Issue.5 , pp. 1605-1612
    • Keilholz, U.1    Goldin-Lang, P.2    Bechrakis, N.E.3    Max, N.4    Letsch, A.5    Schmittel, A.6    Scheibenbogen, C.7    Heufelder, K.8    Eggermont, A.9    Thiel, E.10
  • 31
    • 77952469658 scopus 로고    scopus 로고
    • Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: Prognostic significance of autoantibodies-EORTC 18991
    • 20385998 10.1200/JCO.2009.24.6264 1:CAS:528:DC%2BC3cXnsFOnt74%3D
    • Bouwhuis MG, Suciu S, Testori A, Kruit WH, Sales F, Patel P, Punt CJ, Santinami M, Spatz A, Ten Hagen TL, Eggermont AM (2010) Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies-EORTC 18991. J Clin Oncol 28(14):2460-2466
    • (2010) J Clin Oncol , vol.28 , Issue.14 , pp. 2460-2466
    • Bouwhuis, M.G.1    Suciu, S.2    Testori, A.3    Kruit, W.H.4    Sales, F.5    Patel, P.6    Punt, C.J.7    Santinami, M.8    Spatz, A.9    Ten Hagen, T.L.10    Eggermont, A.M.11
  • 32
    • 79251599240 scopus 로고    scopus 로고
    • Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: A corollary study to EORTC trial 18952
    • 21087856 10.1016/j.ejca.2010.10.005 1:CAS:528:DC%2BC3MXhtlSru7c%3D
    • Bouwhuis MG, Suciu S, Kruit W, Sales F, Stoitchkov K, Patel P, Cocquyt V, Thomas J, Lienard D, Eggermont AM, Ghanem G (2011) Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952. Eur J Cancer 47(3):361-368
    • (2011) Eur J Cancer , vol.47 , Issue.3 , pp. 361-368
    • Bouwhuis, M.G.1    Suciu, S.2    Kruit, W.3    Sales, F.4    Stoitchkov, K.5    Patel, P.6    Cocquyt, V.7    Thomas, J.8    Lienard, D.9    Eggermont, A.M.10    Ghanem, G.11
  • 33
    • 79960701540 scopus 로고    scopus 로고
    • Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-alpha (EORTC 18952) and prognostic value on treatment outcome
    • 21546857 10.1097/CMR.0b013e328346c17f 1:CAS:528:DC%2BC3MXos1amtro%3D
    • Bouwhuis MG, Collette S, Suciu S, de Groot ER, Kruit WH, Ten Hagen TL, Aarden LA, Eggermont AM, Swaak AJ (2011) Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-alpha (EORTC 18952) and prognostic value on treatment outcome. Melanoma Res 21(4):344-351
    • (2011) Melanoma Res , vol.21 , Issue.4 , pp. 344-351
    • Bouwhuis, M.G.1    Collette, S.2    Suciu, S.3    De Groot, E.R.4    Kruit, W.H.5    Ten Hagen, T.L.6    Aarden, L.A.7    Eggermont, A.M.8    Swaak, A.J.9
  • 36
    • 33644988431 scopus 로고    scopus 로고
    • Characterization of CD4 + CD25 + regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma
    • 16505437 10.1200/JCO.2005.03.6830 1:CAS:528:DC%2BD28XislGgsbc%3D
    • Cesana GC, DeRaffele G, Cohen S, Moroziewicz D, Mitcham J, Stoutenburg J, Cheung K, Hesdorffer C, Kim-Schulze S, Kaufman HL (2006) Characterization of CD4 + CD25 + regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. J Clin Oncol 24(7):1169-1177
    • (2006) J Clin Oncol , vol.24 , Issue.7 , pp. 1169-1177
    • Cesana, G.C.1    Deraffele, G.2    Cohen, S.3    Moroziewicz, D.4    Mitcham, J.5    Stoutenburg, J.6    Cheung, K.7    Hesdorffer, C.8    Kim-Schulze, S.9    Kaufman, H.L.10
  • 39
    • 42049089735 scopus 로고    scopus 로고
    • Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors
    • 18381452 10.1158/0008-5472.CAN-07-6822 1:CAS:528:DC%2BD1cXktV2js7o%3D
    • Worschech A, Kmieciak M, Knutson KL, Bear HD, Szalay AA, Wang E, Marincola FM, Manjili MH (2008) Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Cancer Res 68(7):2436-2446
    • (2008) Cancer Res , vol.68 , Issue.7 , pp. 2436-2446
    • Worschech, A.1    Kmieciak, M.2    Knutson, K.L.3    Bear, H.D.4    Szalay, A.A.5    Wang, E.6    Marincola, F.M.7    Manjili, M.H.8
  • 40
    • 57149103930 scopus 로고    scopus 로고
    • Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis
    • 19047140 10.1158/0008-5472.CAN-08-1429 1:CAS:528:DC%2BD1cXhsVegtbrK
    • Huang FJ, Steeg PS, Price JE, Chiu WT, Chou PC, Xie K, Sawaya R, Huang S (2008) Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. Cancer Res 68(23):9634-9642
    • (2008) Cancer Res , vol.68 , Issue.23 , pp. 9634-9642
    • Huang, F.J.1    Steeg, P.S.2    Price, J.E.3    Chiu, W.T.4    Chou, P.C.5    Xie, K.6    Sawaya, R.7    Huang, S.8
  • 42
    • 79955561959 scopus 로고    scopus 로고
    • Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients
    • 10.1186/1479-5876-9-52
    • Simons DL, Lee G, Kirkwood JM, Lee PP (2011) Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients. J Transl Med 5(9):52-60
    • (2011) J Transl Med , vol.5 , Issue.9 , pp. 52-60
    • Simons, D.L.1    Lee, G.2    Kirkwood, J.M.3    Lee, P.P.4
  • 43
    • 0038128204 scopus 로고    scopus 로고
    • High-throughput immunoblotting. Ubiquitin-like protein ISG15 modifies key regulators of signal transduction
    • 12582176 10.1074/jbc.M208435200 1:CAS:528:DC%2BD3sXjsVKnsb4%3D
    • Malakhov MP, Kim KI, Malakhova OA, Jacobs BS, Borden EC, Zhang DE (2003) High-throughput immunoblotting. Ubiquitin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 278(19):16608-16613
    • (2003) J Biol Chem , vol.278 , Issue.19 , pp. 16608-16613
    • Malakhov, M.P.1    Kim, K.I.2    Malakhova, O.A.3    Jacobs, B.S.4    Borden, E.C.5    Zhang, D.E.6
  • 44
    • 77951991690 scopus 로고    scopus 로고
    • Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification
    • 20308324 10.1128/MCB.01466-09 1:CAS:528:DC%2BC3cXmtFymsLk%3D
    • Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, Zhu LH, Wang C (2010) Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 30(10):2424-2436
    • (2010) Mol Cell Biol , vol.30 , Issue.10 , pp. 2424-2436
    • Shi, H.X.1    Yang, K.2    Liu, X.3    Liu, X.Y.4    Wei, B.5    Shan, Y.F.6    Zhu, L.H.7    Wang, C.8
  • 46
    • 77249169773 scopus 로고    scopus 로고
    • Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection
    • e1121-e1123
    • Chen L, Borozan I, Sun J, Guindi M, Fischer S, Feld J, Anand N, Heathcote J, Edwards AM, McGilvray ID (2010) Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection. Gastroenterology 138(3):1123-1133, e1121-e1123
    • (2010) Gastroenterology , vol.138 , Issue.3 , pp. 1123-1133
    • Chen, L.1    Borozan, I.2    Sun, J.3    Guindi, M.4    Fischer, S.5    Feld, J.6    Anand, N.7    Heathcote, J.8    Edwards, A.M.9    McGilvray, I.D.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.